FERRI EMINA

Informazioni principali

  • Nome commerciale:
  • FERRIEMINA OS 10FL 10ML
  • Forma farmaceutica:
  • FLACONCINI OS
  • Composizione:
  • 10 FLACONCINI ORALI 10 ML
  • Classe:
  • C
  • Tipo di ricetta:
  • Ricetta ripetibile, validità 6 mesi, ripetibile 10 volte
  • Utilizzare per:
  • Esseri umani
  • Tipo di medicina:
  • Farmaco allopatico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • FERRIEMINA OS 10FL 10ML
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Iron trivalent oral preparations

Altre informazioni

Status

  • Fonte:
  • AIFA - Agenzia Italiana del Farmaco
  • Numero dell'autorizzazione:
  • 025546021
  • Ultimo aggiornamento:
  • 09-08-2016

Foglio illustrativo

CATEGORIA FARMACOTERAPEUTICA

Ferro trivalente in complesso organico.

INDICAZIONI

Anemia sideropenica.

CONTROINDICAZIONI/EFFETTI SECONDARI

Anemie ipoplastiche, emocromatosi, anemie emolitiche e perniciose

nontrattate, insufficienza renale ed epatica acuta, allergia al

ferro.

POSOLOGIA

ADULTI: 2 flaconcini al giorno durante i pasti.

BAMBINI: 1 flaconcinoal giorno, durante i pasti.

INTERAZIONI

I derivati del ferro possono ridurre l'assorbimento delle

tetracicli-ne.

Il cloramfenicolo puo'ritardare la risposta marziale.

EFFETTI INDESIDERATI

Nausea, vomito, diarrea, reazioni allergiche di tipo anafilattico

(peruso parenterale).

16-10-2018

Pest categorisation of Melampsora farlowii

Pest categorisation of Melampsora farlowii

Published on: Mon, 15 Oct 2018 00:00:00 +0200 Following a request from the European Commission, the EFSA Panel on Plant Health performed a pest categorisation of Melampsora farlowii, a well‐defined and distinguishable fungus of the family Melampsoraceae. M. farlowii is the causal agent of a leaf and twig rust of hemlocks (Tsuga spp.) in eastern North America. The pathogen is regulated in Council Directive 2000/29/EC (Annex IAI) as a harmful organism whose introduction into the EU is banned. M. farlowii ...

Europe - EFSA - European Food Safety Authority Publications

28-9-2018

Debate on research dissemination at the Danish Medicines Agency

Debate on research dissemination at the Danish Medicines Agency

On 1 October, the Danish Medicines Agency and the Danish Society for Pharmacoepidemiology have invited a number of researchers, doctors and communication officers from research institutions throughout Denmark to a debate on how the findings of new health research can be disseminated most responsibly. The debate meeting can be followed live on the Danish Medicines Agency’s Facebook profile.

Danish Medicines Agency

23-6-2017

Substantial progress in cooperation with CFDA only six weeks after state visit

Substantial progress in cooperation with CFDA only six weeks after state visit

During the official state visit at the beginning of May, the Chinese and Danish Ministers for Health and Food signed a Memorandum of Understanding about the establishment of the China-Denmark Food and Drug Regulatory Cooperation Centre. Only six weeks after the state visit, the China Food and Drug Administration (CFDA) and the Danish Medicines Agency held a successful seminar on 20 and 21 June in Beijing on the licensing of medicines and the drafting of a work programme with common activities up to and i...

Danish Medicines Agency

15-5-2018

Rekovelle (Ferring Pharmaceuticals A/S)

Rekovelle (Ferring Pharmaceuticals A/S)

Rekovelle (Active substance: follitropin delta) - Centralised - Yearly update - Commission Decision (2018)2998 of Tue, 15 May 2018

Europe -DG Health and Food Safety